Document Detail


Oral Anticoagulant Use Around the Time of Atrial Fibrillation Ablation: A Review of the Current Evidence of Individual Oral Anticoagulant Use for Periprocedural Atrial Fibrillation Ablation Thromboembolic Prophylaxis.
MedLine Citation:
PMID:  25216104     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Atrial fibrillation is the most common arrhythmia and ablation is becoming more prevalent as a treatment option. Appropriate treatment of atrial fibrillation mandates thromboembolic prophylaxis, and atrial fibrillation ablation periprocedural management of oral anticoagulation is paramount because of the unique susceptibility for thromboembolism that exists for a patient undergoing ablation. Uninterrupted warfarin therapy is the current standard approach for periprocedural atrial fibrillation anticoagulation. Novel oral anticoagulants, including direct thrombin and factor Xa inhibitors, are being used more frequently for thromboembolic prophylaxis in atrial fibrillation patients, but the best strategy for using novel oral anticoagulants in periprocedural anticoagulation is unknown. Optimal periprocedural anticoagulation management strategies with oral anticoagulants, limitations of using novel oral anticoagulants, and future directions in this field are discussed. This article is protected by copyright. All rights reserved.
Authors:
Alex B Garton; John Dudzinski; Peter R Kowey
Related Documents :
3017604 - Scintigraphic quantification of myocardial necrosis in patients after intravenous injec...
8800124 - Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scint...
3665974 - Thallium-201 myocardial scintigraphy in coronary triple-vessel disease: an attempt to i...
22116924 - 36 cyclophilin-d ablation offers long-term protection against acute myocardial ischaemi...
9220184 - Post-traumatic ventricular septal defect following coronary bypass surgery.
19195504 - Effect of acute myocardial infarction on erythrocytic glutathione peroxidase 1 activity...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-12
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  -     ISSN:  1540-8167     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
This article is protected by copyright. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autoreactivity to Glucose Regulated Protein 78 Links Emphysema and Osteoporosis in Smokers.
Next Document:  Using Health Provider Insights to Inform Pediatric HIV Disclosure: A Qualitative Study and Practice ...